Botulinum toxin type A in combination with hemagglutinin, lyophilisate for the solution for intramuscular injection, is a botulinum toxin isolated from Clostridium botulinum type A in combination with hemagglutinin purified by gel chromatography and freeze-dried.

Administration of the preparation in accordance with the approved schedule leads to the development of specific antitoxic immunity to tetanus.

Administration of the preparation in accordance with the approved schedule leads to the development of specific antitoxic immunity to diphtheria and tetanus.

Administration of the preparation in accordance with the approved schedule leads to the development of specific antitoxic immunity to diphtheria.

Administration of the preparation in accordance with the approved schedule leads to the development of specific antitoxic immunity to diphtheria.